dividends
My Visa Long is Getting Long in the Tooth
2017-09-14
Introduction Over my lifetime I have invested in many different things. In the process of doing that, I have learned that there are really only two types of investors. As an investor, you are either active or passive. Being active implies directly managing or being in control of your investment. In contrast, as a passive […]
Choosy Investors Choose J.M. Smucker and The Dividend Adds Value
2017-09-07
Introduction The J.M. Smucker Company (SJM) is a “Dividend Contender” that has increased its dividend for 20 consecutive years. After being overvalued for most of fiscal year 2017 (fiscal year ends in April) the company has since fallen into attractive valuation territory. As a result, the company is available at a low P/E ratio relative […]
This Is Not Your Grandfather’s AT&T
2017-07-27
Introduction I have had several readers request that I do an article on AT&T (T). Since the company has just reported earnings, which have thus far received a strong and positive reaction from Wall Street, I thought now would be a good time. Following their earnings report, an article published on July 25, 2017 at […]
The Active versus Passive Performance Debate Is Nonsensical
2017-05-18
Research Articles, Uncategorized
Introduction One of the most hotly contested debates in finance is the argument over which is better – active or passive investing. Moreover, this debate has spurred numerous academic studies that claim to identify whether passive outperforms active investing or vice versa. As a result, the current popular opinion suggests that passive outperforms active investing […]
j2 Global: Don’t Overlook This Impressive Growth and Dividend Income Stock
2017-03-03
Investment Thesis j2 Global (JCOM) was founded in 1995 and went public in 1999. During their first few years as a public company, j2 Global generated operating losses; however, since 2002 the company has strung together an impressive record of rapid growth. They initiated their first dividend in 2011, and on February 9, 2017 they […]
Pfizer Inc. Invest For Attractive Valuation and The 4% Dividend Yield
2017-02-22
Investment Thesis Pfizer Inc (PFE) is one of the world’s largest pharmaceutical firms with sales exceeding $50 billion. The company is currently attractively valued at a blended P/E ratio of 13.3, offering a current dividend yield of 4%. Pfizer is awarded an S&P credit rating of AA and possesses a modest debt to capital ratio […]